Literature DB >> 23810061

Bilirubin influences the clinical presentation of pre-eclampsia.

Eamonn Breslin1, Angelika Kaufmann, Siobhan Quenby.   

Abstract

OBJECTIVES: Pre-eclampsia is a placental, inflammatory disease modified by maternal anti-oxidant status to give a syndrome. In its most severe forms pre-eclampsia is followed by maternal and neonatal mortality and morbidity. Bilirubin is a known antioxidant and as such is associated with a reduced risk of cardiovascular and respiratory disease. Hence we aimed to find an association between maternal bilirubin levels and the clinical severity of the disease. STUDY
DESIGN: A retrospective observational study of 50,712 pregnancies, 925 of which had pre-eclampsia (1999-2010), to examine the association between bilirubin level and perinatal outcome.
RESULTS: In women with pre-eclampsia, those with bilirubin levels in the lowest quintile were more likely to require caesarean section (p=0.001, aOR 2.59 (1.52-5.72)). The lowest quintile of bilirubin levels is associated with an increased risk of poor maternal (p=0.002, aOR 3.52 (95%CI 1.6-7.7)) and infant/fetal (p=0.001, OR=3.05 (95%CI=1.63-5.72)) outcome.
CONCLUSIONS: Low levels of bilirubin were associated with poor maternal and infant outcomes in women diagnosed with pre-eclampsia. Bilirubin may act as an anti-oxidant in this condition and thus modify the disease.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Bilirubin; Outcome; Pre-eclampsia; Prediction

Mesh:

Substances:

Year:  2013        PMID: 23810061     DOI: 10.1016/j.ejogrb.2013.05.024

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  2 in total

Review 1.  Therapeutic potential of statins and the induction of heme oxygenase-1 in preeclampsia.

Authors:  Wenda Ramma; Asif Ahmed
Journal:  J Reprod Immunol       Date:  2014-01-16       Impact factor: 4.054

2.  Predictive value of serum uric acid levels for adverse perinatal outcomes in preeclampsia.

Authors:  Aelie Ryu; Nam Jun Cho; Yun Sook Kim; Eun Young Lee
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.